Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv:: effect of different acylating reagents

被引:13
作者
Kim, I
Kobayashi, H
Yoo, TM
Kim, MK
Le, N
Han, ES
Wang, QC
Pastan, I
Carrasquillo, JA
Paik, CH
机构
[1] NIH, Dept Nucl Med, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA
[2] NCI, Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
关键词
Tc-99m-MAG3-dsFv; isoelectric point; enhanced renal clearance;
D O I
10.1016/S0969-8051(02)00341-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Anti-Tac disulfide-stabilized variable region fragment (dsFv) was labeled with Tc-99m by a preformed chelate approach using Tc-99m-MAG3-trifluorophenyl (TFP) ester. Simultaneously it was acylated with TFP-lactate or succinic anhydride to decrease the isoelectric point of dsFv (pI 10). Acylation of dsFv (0.04 mM) with the lactate at a 73 times molar excess reduced the pI to 5.0-6.7, whereas acylation with succinic anhydride at a 30 times molar excess reduced the pI to 4.9-8.7. Comparative biodistribution studies performed in mice (n = 5) showed the reduced renal accumulation of the Tc-99m proportional to the pI reduction. The effect of the pI on the reduced renal uptake was especially pronounced at 15 min postinjection. The reduced renal uptake was also reflected in the reduced whole-body retention, indicating that lowering the pI inhibited the tubular reabsorption of the labeled dsFv. Published by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:795 / 801
页数:7
相关论文
共 39 条
[1]  
ADAMS GP, 1993, CANCER RES, V53, P4026
[2]  
BEHR TM, 1995, CANCER RES, V55, P3825
[3]   Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy [J].
Breitz, HB ;
Tyler, A ;
Bjorn, MJ ;
Lesley, T ;
Weiden, PL .
CLINICAL NUCLEAR MEDICINE, 1997, 22 (09) :615-620
[4]  
CHOI CW, 1995, CANCER RES, V55, P5323
[5]  
DEPALATIS LR, 1995, CANCER RES, V55, P5288
[6]  
FRITZBERG AR, 1986, J NUCL MED, V27, P111
[7]  
Goel A, 2000, CANCER RES, V60, P6964
[8]  
Goldenberg D M, 1997, J Nucl Med Technol, V25, P18
[9]   PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY [J].
GREENWOOD, FC ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1963, 89 (01) :114-&
[10]   CHARGE SELECTIVITY OF THE GLOMERULAR-FILTRATION BARRIER IN HEALTHY AND NEPHROTIC HUMANS [J].
GUASCH, A ;
DEEN, WM ;
MYERS, BD .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2274-2282